How do I buy Beam Therapeutics (BEAM) stock?

You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.View our list of the best stock brokerages

Who are Beam Therapeutics (BEAM) competitors?

Other companies in Beam Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Immunome Inc (NASDAQ:IMNM), Sarepta Therapeutics Inc (NASDAQ:SRPT), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Ascentage Pharma Group International (NASDAQ:AAPG).

What is the forecast, or price target, for Beam Therapeutics (BEAM) stock?

Beam Therapeutics has a consensus price target of $48.23.

What is the current price for Beam Therapeutics (BEAM)?

The stock price for Beam Therapeutics (NASDAQ: BEAM) is $33.6001 last updated January 12, 2026 at 7:42 PM EST.

Does Beam Therapeutics (BEAM) pay a dividend?

There are no upcoming dividends for Beam Therapeutics.

When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?

Beam Therapeutics does not have any upcoming earnings scheduled.

Is Beam Therapeutics (BEAM) going to split?

There is no upcoming split for Beam Therapeutics.

What sector and industry does Beam Therapeutics (BEAM) operate in?

Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Beam Therapeutics (BEAM) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases....

Comments